Astrana Health, INC 10-Q quarterly reports

Astrana Health, Inc. (ASTH) announced robust financial results for the second quarter ended June 30, 2026, showcasing significant revenue increases and improved net income, largely driven by the strategic acquisition of Prospect Medical Holdings.

Astrana Health, Inc. (ASTH) announced a significant increase in revenue and net income for the first quarter of 2026, driven by strategic acquisitions and organic growth.

Astrana Health, Inc. reported a significant 100% increase in total revenue for Q3 2025, reaching $956.0 million, primarily driven by the acquisition of Prospect Medical Holdings, Inc., despite a substantial drop in net income.

Astrana Health reports significant revenue growth driven by recent acquisitions, despite a decline in net income and operating profit for the second quarter and first half of 2025.

Astrana Health's Q1 2025 revenue increased by 53% year-over-year, driven by capitation growth, while net income saw a decrease.

Astrana Health's third quarter 2024 results show a significant 37% increase in revenue, driven primarily by capitation growth and recent acquisitions.

Astrana Health, Inc. saw a significant increase in revenue during the second quarter of 2024, primarily driven by recent strategic acquisitions and growth in capitation revenue.

Astrana Health's first quarter of 2024 saw a 20% increase in revenue, driven by strategic acquisitions and growth in capitation revenue.